Protagenic Therapeutics, Inc.\new Goodwill, Fair Value Disclosure
Protagenic Therapeutics, Inc.\new (PTIX) had Goodwill, Fair Value Disclosure of $0 as of 2016-02-12, per its 10-K/A filed 2017-05-08.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:GoodwillFairValueDisclosure · last filed 2017-05-08
- 2016-02-12: Goodwill, Fair Value Disclosure $0.00.
| Period end | Goodwill, Fair Value Disclosure |
|---|---|
| 2016-02-12 | $0.00 10-K/A · filed 2017-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |